StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) income statement

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$151.02−5.21 (-3.33%)

Close on Nov 19, 2026Market cap $5.94BP/E –Yield –

See a number that looks wrong?